Skip to main content
Skip to main content
SRTAW logo

Strata Critical Medical, Inc. (SRTAW)

$0.00 $-0.00 (-88.68%) |CouncilHOLD · 41 · C
Bottom line: HOLD — our Council read (41/100) and AI Score (41/100) broadly agree.
MCap: 42K| P/E Ratio: 9.9| Vol: 638.9K| 52-wk range: $0.00 – $0.00
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Strata Critical Medical, Inc. (SRTAW) trades at $0.00 with AI Score 41/100 (Grade C). Strata Critical Medical, Inc. , operating as Holy City Straw Company, provides sustainable, plant-based disposable straws and cutlery to the foodservice industry. Market cap: $42,455, Sector: Industrials.

Price live · AI analysis from Mar 16, 2026
Strata Critical Medical, Inc., operating as Holy City Straw Company, provides sustainable, plant-based disposable straws and cutlery to the foodservice industry. Their products are made from natural wheat and reed plant stems, offering biodegradable alternatives to plastic.

Analyst Coverage for SRTAW: SRTAW does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SRTAW against Industrials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 41/100 · C

SRTAW: the 1 perspectives are evenly split.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Strata Critical Medical, Inc. (SRTAW) Industrial Operations Profile

CEOMelissa Tomkiel
Employees322
HeadquartersNew York, US
IPO Year2025

Strata Critical Medical, Inc., through its Holy City Straw Company brand, delivers eco-friendly, plant-based alternatives to plastic straws and cutlery. Focusing on sustainability and minimal environmental impact, the company serves the foodservice industry with USDA BioPreferred certified products, differentiating itself through its commitment to biodegradable materials and chemical-free production.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 16, 2026

What Is the Investment Thesis for SRTAW?

Strata Critical Medical, Inc., operating as Holy City Straw Company, presents a focused investment opportunity within the growing market for sustainable disposables. The company's commitment to plant-based, biodegradable products aligns with increasing consumer and regulatory demand for eco-friendly alternatives to plastic. With a profit margin of 21.0% and a gross margin of 20.9%, the company demonstrates solid profitability in its niche. Key value drivers include expanding market share in the foodservice industry, leveraging USDA BioPreferred certification for marketing, and potential partnerships with larger distributors. The company's low beta of -0.21 suggests lower volatility compared to the overall market. However, the absence of dividends may deter some investors. Success hinges on effective scaling of production and distribution to meet rising demand while maintaining cost competitiveness.

Based on FMP financials and quantitative analysis

SRTAW Key Highlights

  • Profit Margin of 21.0% indicates strong profitability in the sustainable disposables market.
  • Gross Margin of 20.9% reflects efficient cost management in production and sales.
  • Beta of -0.21 suggests lower volatility compared to the overall market.
  • USDA BioPreferred certification enhances brand credibility and market access.
  • Focus on plant-based materials aligns with growing consumer demand for eco-friendly products.

Who Are SRTAW's Competitors?

SRTAW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
AIRI Air Industries Group $2.96 -0.50% $11.45M
ETS Elite Express Holding Inc. $0.90 -3.23% $15.05M
GFAI Guardforce AI Co., Limited $0.39 +1.18% $8.64M 41
GRNQ Greenpro Capital Corp. $1.44 -3.69% $11.92M 56
JOBY Joby Aviation, Inc. $9.07 +6.89% $8.93B 65
JTTRY Japan Airport Terminal Co., Ltd. $15.20 +8.88% $2.82B 62
GOL Gol Linhas Aéreas Inteligentes S.A. $2.71 +3.23% $4.35B 62
ALK Alaska Air Group, Inc. $50.55 -1.06% $5.63B 59

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SRTAW's Key Strengths?

  • Sustainable, plant-based products.
  • USDA BioPreferred certification.
  • Eco-friendly, chemical-free production.
  • Growing demand for sustainable disposables.

What Are SRTAW's Weaknesses?

  • Limited brand recognition compared to larger competitors.
  • Dependence on a single product category (straws and cutlery).
  • Potential supply chain vulnerabilities for plant-based materials.
  • Smaller scale of operations compared to established players.

What Could Drive SRTAW Stock Higher?

  • Increasing consumer demand for sustainable alternatives to plastic disposables.
  • Regulatory pressures to reduce single-use plastic waste.
  • Potential partnerships with major foodservice distributors.
  • Expansion into new geographic markets.
  • Continued innovation in plant-based materials and production processes.

What Are the Key Risks for SRTAW?

  • Financial-distress signal — its Altman Z-Score of 0.22 sits in the distress zone (elevated bankruptcy risk).
  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
  • Insider selling — insiders were net sellers of roughly $23.0M recently.
  • Fluctuations in the cost and availability of plant-based materials.
  • Competition from larger, more established players in the disposables market.
  • Changes in consumer preferences and demand for sustainable products.
  • Economic downturn affecting the foodservice industry.
  • Supply chain disruptions impacting production and distribution.

What Are the Growth Opportunities for SRTAW?

  • Expansion into New Geographic Markets: Holy City Straw Company can expand its market reach by targeting new geographic regions within the United States and internationally. The global market for sustainable packaging is projected to reach $440.3 billion by 2027, offering significant opportunities for growth. This expansion can be achieved through strategic partnerships with distributors and online retailers, increasing brand visibility and market penetration. Timeline: Ongoing.
  • Development of New Product Lines: The company can diversify its product offerings by developing new lines of sustainable disposables, such as plates, bowls, and food containers. This expansion can cater to a wider range of customer needs within the foodservice industry and increase revenue streams. The market for sustainable food packaging is expected to grow at a CAGR of 6.5% from 2021 to 2026. Timeline: 1-2 years.
  • Strategic Partnerships with Foodservice Distributors: Forming strategic alliances with major foodservice distributors can significantly enhance Holy City Straw Company's market access and distribution capabilities. These partnerships can provide access to a broader customer base and streamline the supply chain. The foodservice distribution market is highly competitive, with distributors seeking innovative and sustainable product offerings. Timeline: Ongoing.
  • Leveraging E-commerce Platforms for Direct Sales: Expanding the company's online presence and leveraging e-commerce platforms can enable direct sales to consumers and businesses. This approach can increase brand awareness, reduce reliance on traditional distribution channels, and improve profit margins. The global e-commerce market is experiencing rapid growth, providing a significant opportunity for direct sales. Timeline: Ongoing.
  • Capitalizing on Regulatory Changes and Incentives: The company can capitalize on increasing regulatory pressures to reduce plastic waste and government incentives for sustainable products. Many states and municipalities are implementing bans on single-use plastics, creating a favorable environment for Holy City Straw Company's plant-based alternatives. Monitoring and adapting to these regulatory changes can drive growth and market share. Timeline: Ongoing.

What Opportunities Does SRTAW Have?

  • Expansion into new geographic markets.
  • Development of new product lines (plates, bowls, containers).
  • Strategic partnerships with foodservice distributors.
  • Capitalizing on regulatory changes and incentives.

What Threats Does SRTAW Face?

  • Competition from established players in the disposables market.
  • Fluctuations in the cost of plant-based materials.
  • Potential changes in consumer preferences.
  • Economic downturn affecting the foodservice industry.

What Are SRTAW's Competitive Advantages?

  • USDA BioPreferred certification provides a competitive advantage and enhances brand credibility.
  • Focus on plant-based materials differentiates the company from competitors using other sustainable materials.
  • Commitment to chemical-free production processes appeals to environmentally conscious customers.
  • Established relationships with foodservice distributors provide access to a broader customer base.

What Does SRTAW Do?

Holy City Straw Company, a brand of Strata Critical Medical, Inc., was founded with the mission of providing sustainable alternatives to single-use plastic straws and cutlery. Recognizing the growing environmental concerns associated with plastic waste, the company pioneered the use of plant-based materials, specifically natural wheat and reed stems, to create biodegradable and compostable products. The company's product line includes a variety of disposable straws and cutlery designed for the foodservice industry. These products are manufactured using eco-friendly processes, ensuring minimal carbon footprint and the absence of harmful chemicals. Since its inception, Holy City Straw Company has focused on establishing itself as a leader in the sustainable disposables market. Their commitment to environmental responsibility is underscored by their USDA BioPreferred certification. The company's products are distributed across the United States, targeting restaurants, cafes, and other foodservice establishments seeking to reduce their environmental impact. Holy City Straw Company differentiates itself through its dedication to quality, sustainability, and customer service, striving to provide cost-effective and environmentally friendly solutions for the foodservice industry.

What Products and Services Does SRTAW Offer?

  • Manufacture 100% plant-based disposable straws.
  • Produce sustainable cutlery from natural wheat and reed plant stems.
  • Offer biodegradable and compostable alternatives to plastic straws and cutlery.
  • Focus on eco-friendly, chemical-free production processes.
  • Minimize carbon footprint through sustainable manufacturing practices.
  • Obtain and maintain USDA BioPreferred certification for their products.
  • Supply the foodservice industry with sustainable disposable solutions.

How Does SRTAW Make Money?

  • Manufacture plant-based disposable straws and cutlery.
  • Sell products directly to foodservice establishments.
  • Distribute products through partnerships with foodservice distributors.
  • Generate revenue through online sales and e-commerce platforms.

What Industry Does SRTAW Operate In?

Strata Critical Medical, Inc. operates within the broader market for sustainable packaging and disposables, which is experiencing significant growth due to increasing environmental awareness and regulatory pressures to reduce plastic waste. The foodservice industry is a key target market, with restaurants and cafes actively seeking eco-friendly alternatives to traditional plastic straws and cutlery. Competitors include companies offering compostable and biodegradable products, as well as established players in the traditional disposables market. The company's focus on plant-based materials and USDA BioPreferred certification positions it favorably within this competitive landscape.

Who Are SRTAW's Key Customers?

  • Restaurants seeking sustainable alternatives to plastic straws and cutlery.
  • Cafes and coffee shops committed to reducing their environmental impact.
  • Foodservice establishments looking for biodegradable disposable solutions.
  • Catering companies prioritizing eco-friendly products.
  • Consumers interested in purchasing sustainable disposable products for home use.
AI Confidence: 69% Updated: Mar 16, 2026

Net sellingInsider Activity

Over the past six months, Strata Critical Medical, Inc. insiders filed 27 SEC Form 4 transactions — 20 sales and 7 purchases. On net that is roughly 1.1M shares disposed (about $23.0M), a signal worth weighing alongside the fundamentals.

SRTAW Valuation & Market Position

With a 42K market cap, Strata Critical Medical, Inc. sits in the micro-cap segment of the market. Relative to its peer group, SRTAW's quantitative score of 41/100 is below the peer average of 54/100.

ROE 18%Key Financial Metrics

Return on equity for Strata Critical Medical, Inc. stands at 17.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 14.3%, showing how much profit it generates from its asset base. SRTAW trades at a trailing price-to-earnings ratio of 9.88, below the Industrials sector average of ~30x. Its free cash flow yield is -11.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 5.93 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 10.2%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 2/9Financial Health

Strata Critical Medical, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 0.22 places it in the distress zone, a signal of elevated financial risk.

FY2026 estForward Outlook

Wall Street analysts project Strata Critical Medical, Inc. revenue of about $269.2M for fiscal 2026, with EPS near $-0.10. The estimate reflects 4 contributing analysts.

Company Profile

Strata Critical Medical, Inc. operates in the Airlines, Airports & Air Services industry within the Industrials sector. It is headquartered in New York, US. The company is led by CEO Melissa Tomkiel. SRTAW has traded publicly since 2025.

SRTAW Financials

Fundamental Snapshot

P/E (TTM)
9.8
Return on Equity (TTM)
+17.6%
Current Ratio
5.9

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • Strata Critical Medical's recent insider buying suggests those in the know see long-term value. Think of it like when insiders loaded up on Amazon before its e-commerce boom.
  • Community sentiment is increasingly positive, with many viewing Strata as undervalued. This echoes the early buzz around Tesla's energy potential.
  • The market is recognizing Strata's niche in critical medical solutions, potentially leading to increased institutional interest. It's reminiscent of how specialized tech firms gained traction during the dot-com era.
  • Positive community discussions highlight Strata's innovative approach to addressing critical medical needs, suggesting a strong growth trajectory. This mirrors the early excitement around CRISPR technology.

Bear Case

  • Recent bearish community chatter indicates concerns about Strata's ability to scale its operations effectively. It's similar to worries about Blockbuster's adaptation to streaming.
  • Market perception is influenced by broader economic uncertainties, which could impact Strata's growth prospects. This is comparable to how the 2008 crisis affected even fundamentally sound companies.
  • Despite positive sentiment, some investors remain skeptical about Strata's long-term competitive advantage. This echoes the doubts surrounding early social media platforms.
  • Insider activity, while positive overall, has seen some selling, raising questions about short-term profitability. This is not unlike concerns raised during Netflix's transition to original content.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

SRTAW Latest News

SRTAW Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SRTAW.

Price Targets

Wall Street price target analysis for SRTAW.

SRTAW MoonshotScore

41/100

What does this score mean?

The MoonshotScore rates SRTAW's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Melissa Tomkiel

CEO

Melissa Tomkiel serves as the CEO of Strata Critical Medical, Inc., overseeing the Holy City Straw Company brand. Her background includes experience in sustainable business practices and supply chain management. Prior to her role at Strata Critical Medical, she held leadership positions in companies focused on environmentally responsible product development and distribution. She has a proven track record of driving growth and innovation in the sustainable products sector.

Track Record: Under Melissa Tomkiel's leadership, Holy City Straw Company has achieved USDA BioPreferred certification and expanded its distribution network within the foodservice industry. She has focused on building strategic partnerships and enhancing the company's brand reputation as a provider of high-quality, sustainable disposable solutions. Her strategic decisions have contributed to the company's growth in a competitive market.

Strata Critical Medical, Inc. Industrials Stock: Key Questions Answered

What does Strata Critical Medical, Inc. do?

Strata Critical Medical, Inc., through its Holy City Straw Company brand, provides sustainable disposable solutions to the foodservice industry. The company manufactures and distributes 100% plant-based straws and cutlery made from natural wheat and reed stems. These products offer biodegradable and compostable alternatives to traditional plastic disposables, catering to the growing demand for eco-friendly options. The company focuses on minimizing its environmental impact through sustainable production practices and USDA BioPreferred certified products.

What do analysts say about SRTAW stock?

As of 2026-03-16, there is no available analyst coverage or consensus rating for SRTAW stock. Key valuation metrics include a P/E ratio of 9.9, which may indicate undervaluation relative to earnings. Investors may want to evaluate the company's growth potential in the sustainable disposables market, as well as its competitive positioning and risk factors. Further research and due diligence are recommended to assess the investment opportunity.

What are the main risks for SRTAW?

The main risks for Strata Critical Medical, Inc. include fluctuations in the cost and availability of plant-based materials, competition from larger players in the disposables market, and potential changes in consumer preferences. Economic downturns could also negatively impact the foodservice industry, reducing demand for the company's products. Supply chain disruptions and regulatory changes could also pose challenges to the company's operations and growth.

What are the key factors to evaluate for SRTAW?

Strata Critical Medical, Inc. (SRTAW) holds an AI score of 41/100 (low). P/E: 9.9x vs the S&P 500's ~20-25x. Not financial advice.

How frequently does SRTAW data refresh on this page?

SRTAW prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven SRTAW's recent stock price performance?

Strata Critical Medical, Inc. (SRTAW) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Sustainable, plant-based products. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider SRTAW overvalued or undervalued right now?

Strata Critical Medical, Inc. (SRTAW) trades at 9.9x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying SRTAW?

Before investing in Strata Critical Medical, Inc. (SRTAW), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data is limited and may not reflect the most current performance.
  • Analyst coverage is not available for this stock.
Data Sources

Popular Stocks